sibutramine has been researched along with Morbid Obesity in 19 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
| Excerpt | Relevance | Reference |
|---|---|---|
| "To describe our experience using sibutramine in weight reduction treatment of adolescents suffering from morbid obesity." | 9.12 | Sibutramine as an adjuvant therapy in adolescents suffering from morbid obesity. ( Afriat, R; Bortnik, O; Goldman, M; Reisler, G; Tauber, T, 2006) |
| "To describe our experience using sibutramine in weight reduction treatment of adolescents suffering from morbid obesity." | 5.12 | Sibutramine as an adjuvant therapy in adolescents suffering from morbid obesity. ( Afriat, R; Bortnik, O; Goldman, M; Reisler, G; Tauber, T, 2006) |
| " The USA, the European Union and Norway have approved orlistat, a pancreatic lipase inhibitor for weight reduction for up to two years." | 4.80 | [The obesity epidemics--do diet pills have a place in the treatment?]. ( Birkeland, KI; Tonstad, S, 2000) |
| "Topiramate (alone or associated with sibutramine) and orlistat (alone or in combination) promoted significant weight loss after 2 years of use in patients submitted to bariatric surgery with weight regain." | 4.31 | Treatment with Antiobesity Drugs in Weight Regain After Bariatric Surgery: a Retrospective Cohort Study. ( Boger, BS; Canuto, MC; Cercato, C; de Melo, ME; Mancini, MC; Noriega, PEP; Queiroz, NL; Stumpf, MAM, 2023) |
| "In the management of obesity, using BIB together with sibutramine before the treatment in the patient group who are planned to have surgery, compared with using only BIB, provides more effective weight loss." | 3.76 | Assessment of the application of the intragastric balloon together with sibutramine: a prospective clinical study. ( Bostanci, O; Coskun, H, 2010) |
| "We, therefore, conducted a study in which 20 bariatric patients received 15 mg of the weight loss medication sibutramine prior to laparoscopic Roux-en-Y gastric bypass (RYGBP) while patients in the control group did not." | 3.75 | Treatment with sibutramine prior to Roux-en-Y gastric bypass leads to an improvement of metabolic parameters and to a reduction of liver size and operative time. ( Aberle, J; Beil, FU; Busch, P; Dannheim, V; Freier, A; Mann, O; Mommsen, N, 2009) |
| " A high serum folic acid level was the only independent predictor of weight loss at 1 year." | 3.73 | Baseline serum folate level may be a predictive factor of weight loss in a morbid-obesity-management programme. ( Candil, SD; Martínez, JJ; Ruiz, FA, 2006) |
| "Drug treatment of obesity offer a possible adjunct, but it may only have modest results, limited by side effects; furthermore, the weight lowering effects last only as long as the drug is being taken and, unfortunately, as soon as the administration is stopped, the weight is regained." | 2.48 | [The pharmacological treatment of obesity: past, present and future]. ( Bedros, JR; Medvegy, M; Pados, G; Simonyi, G, 2012) |
| " A multifaceted approach to the obese patient should include identifying potential causes for weight gain, outlining medical conditions that would benefit by weight loss, and tailoring a weight loss program that is safe and effective for the individual." | 2.40 | Safe and effective management of the obese patient. ( Collazo-Clavell, ML, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 13 (68.42) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Boger, BS | 1 |
| Queiroz, NL | 1 |
| Noriega, PEP | 1 |
| Canuto, MC | 1 |
| Stumpf, MAM | 1 |
| Cercato, C | 1 |
| Mancini, MC | 1 |
| de Melo, ME | 1 |
| Slovacek, L | 1 |
| Pavlik, V | 1 |
| Slovackova, B | 1 |
| Coskun, H | 1 |
| Bostanci, O | 1 |
| Aberle, J | 1 |
| Freier, A | 1 |
| Busch, P | 1 |
| Mommsen, N | 1 |
| Beil, FU | 1 |
| Dannheim, V | 1 |
| Mann, O | 1 |
| Simonyi, G | 1 |
| Pados, G | 1 |
| Medvegy, M | 1 |
| Bedros, JR | 1 |
| Svendsen, OL | 1 |
| Reisler, G | 1 |
| Tauber, T | 1 |
| Afriat, R | 1 |
| Bortnik, O | 1 |
| Goldman, M | 1 |
| Martínez, JJ | 1 |
| Ruiz, FA | 1 |
| Candil, SD | 1 |
| Suter, PM | 1 |
| Kolyvanos, NU | 1 |
| Käser, L | 1 |
| Vetter, W | 1 |
| Bahadori, B | 1 |
| Uitz, E | 1 |
| Tonninger-Bahadori, K | 1 |
| Moghadasian, MH | 1 |
| Nau, JY | 1 |
| Aylwin, S | 1 |
| Al-Zaman, Y | 1 |
| Esposito, P | 1 |
| Rampino, T | 1 |
| Gregorini, M | 1 |
| Soccio, G | 1 |
| Piotti, G | 1 |
| Bedino, G | 1 |
| Balenzano, CT | 1 |
| Roscini, E | 1 |
| Cosmai, L | 1 |
| Portalupi, V | 1 |
| Libetta, C | 1 |
| Dal Canton, A | 1 |
| Van Gaal, LF | 1 |
| Peiffer, FW | 1 |
| De Leeuw, IH | 1 |
| Greenberg, I | 1 |
| Chan, S | 1 |
| Blackburn, GL | 1 |
| Collazo-Clavell, ML | 1 |
| Kunt, T | 1 |
| Tonstad, S | 1 |
| Birkeland, KI | 1 |
7 reviews available for sibutramine and Morbid Obesity
| Article | Year |
|---|---|
[The pharmacological treatment of obesity: past, present and future].
Topics: Amides; Anti-Obesity Agents; Anticonvulsants; Antidepressive Agents; Basal Metabolism; Benzazepines; | 2012 |
[Obesity in adults].
Topics: Adult; Aged; Anti-Obesity Agents; Appetite Depressants; Bariatric Surgery; Body Mass Index; Cyclobut | 2007 |
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Baria | 2008 |
Nonpharmacologic and pharmacologic management of weight gain.
Topics: Anti-Obesity Agents; Appetite Depressants; Behavior Therapy; Cyclobutanes; Diet, Reducing; Energy In | 1999 |
Safe and effective management of the obese patient.
Topics: Anti-Obesity Agents; Appetite Depressants; Cognitive Behavioral Therapy; Cyclobutanes; Exercise; Gas | 1999 |
[The obesity epidemics--do diet pills have a place in the treatment?].
Topics: Anti-Obesity Agents; Appetite Depressants; Cyclobutanes; Fenfluramine; Humans; Lactones; Leptin; Obe | 2000 |
[SEEDO'2000 consensus for the evaluation of overweight and obesity and the establishment of criteria for therapeutic intervention. Sociedad Española para el Estudio de la Obesidad].
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Obesity Agents; Appetite Depressants; Biliopancreatic Div | 2000 |
1 trial available for sibutramine and Morbid Obesity
| Article | Year |
|---|---|
Sibutramine as an adjuvant therapy in adolescents suffering from morbid obesity.
Topics: Adolescent; Appetite Depressants; Chemotherapy, Adjuvant; Cyclobutanes; Diet, Reducing; Female; Huma | 2006 |
11 other studies available for sibutramine and Morbid Obesity
| Article | Year |
|---|---|
Treatment with Antiobesity Drugs in Weight Regain After Bariatric Surgery: a Retrospective Cohort Study.
Topics: Aged; Anti-Obesity Agents; Bariatric Surgery; Female; Humans; Male; Middle Aged; Obesity, Morbid; Or | 2023 |
The effect of sibutramine therapy on occurrence of depression symptoms among obese patients.
Topics: Antidepressive Agents; Appetite Depressants; Body Mass Index; Cyclobutanes; Depression; Humans; Long | 2008 |
Assessment of the application of the intragastric balloon together with sibutramine: a prospective clinical study.
Topics: Adult; Appetite Depressants; Body Mass Index; Combined Modality Therapy; Cyclobutanes; Female; Gastr | 2010 |
Treatment with sibutramine prior to Roux-en-Y gastric bypass leads to an improvement of metabolic parameters and to a reduction of liver size and operative time.
Topics: Adult; Appetite Depressants; Cyclobutanes; Female; Gastric Bypass; Humans; Liver; Male; Obesity, Mor | 2009 |
[Pharmacotherapy of obesity].
Topics: Anti-Obesity Agents; Appetite Depressants; Clinical Trials as Topic; Cyclobutanes; Evidence-Based Me | 2004 |
Baseline serum folate level may be a predictive factor of weight loss in a morbid-obesity-management programme.
Topics: Adolescent; Adult; Anti-Obesity Agents; Appetite Depressants; Biomarkers; Cyclobutanes; Eating; Fema | 2006 |
Successful treatment of a morbidly obese and growth-retarded adolescent with Williams-Beuren Syndrome by combining the medication of growth hormone and sibutramine.
Topics: Adolescent; Appetite Depressants; Body Composition; Body Mass Index; Body Weight; Cyclobutanes; Huma | 2008 |
[Antiobesity drugs--new limitations].
Topics: Anti-Obesity Agents; Appetite Depressants; Cyclobutanes; Depression; Drug Therapy, Combination; Evid | 2007 |
Severe symptomatic hyponatremia during sibutramine therapy: a case report.
Topics: Appetite Depressants; Body Mass Index; Cyclobutanes; Diagnosis, Differential; Emergency Service, Hos | 2008 |
New pharmacological directions for the treatment of overweight and obesity.
Topics: Anti-Obesity Agents; Appetite Depressants; Body Mass Index; Body Weight; Cyclobutanes; Enzyme Inhibi | 1999 |
[Obesity: when does the internist recommend surgery?].
Topics: Adult; Appetite Depressants; Body Weight; Cyclobutanes; Female; Humans; Male; Middle Aged; Obesity, | 2000 |